References
- 1. Relman AS. The acidosis of renal disease. Am J Med. 1968; 44:706-13.10.1016/0002-9343(68)90252-0
- 2. Chan JCM. Nutrition and acid-base metabolism. Federation Proc. 40:2423-8, 1981.
- 3. Winters RW. The body fluids in pediatrics. Boston: Little Brown and Co, 1973.
- 4. Chan JCM. Acid-base disorders and the kidney. Adv Pediatr. 1983; 30:401-71.10.1016/S0065-3101(22)00585-0
- 5. Relman AS, Kurtz I. Milestones in nephrology. Feature editor: M A Knepper. J Am Soc Nephrol. 2000; 11:2155-64.10.1681/ASN.V11112155
- 6. Goodman AD, Lemann J Jr, Lennon EJ, Relman AS. Production, excretion, and net balance of fixed acid in patients with renal acidosis. J Clin Invest. 1965; 44: 495-506.10.1172/JCI105163
- 7. Relman AR, Lennon EJ, Lemann J Jr. Endogenous production of fixed acid and the measurement of the net balance of acid in normal subjects. J Clin Invest. 1961; 40:1621-30.10.1172/JCI104384
- 8. Chan JCM, Goplerud JM, Papadopoulou ZL, Novello AC. Kidney failure in childhood. Int J Pediatr Nephrol. 1981; 2:201-22.
- 9. Rodriguez-Soriano J, Vallo A, Castillo G, Oliveros, R. Natural history of primary distal renal tubular acidosis treated since infancy. J Pediatr. 1982; 101:669-76.10.1016/S0022-3476(82)80288-6
- 10. Norman ME, Feldmn NI, Cohn RM, Roth KS, McCurdy DK. Urinary citrate excretion in the diagnosis of distal renal tubular acidosis. J Pediatr. 1978; 92: 394-400.10.1016/S0022-3476(78)80426-0
- 11. Chan JCM. Renal tubular acidosis: Medical progress. J Pediatr. 1983; 102:327-40.10.1016/S0022-3476(83)80644-1
- 12. Nordin BEC. Calcium, phosphate and magnesium metabolism. London: Churchill Livingston; 1976.
- 13. Lee SW, Russell J, Avioli LV. 25 hydroxycholecalciferol to 1, 25 dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. Science. 1977; 195: 994-6.10.1126/science.841324
- 14. Chesney RW, Kaplan BS, Phelps M, DeLuca HP. Renal tubular acidosis does not alter circulating values of calcitriol. J Pediatr. 1984; 104:51-5.10.1016/S0022-3476(84)80588-0
- 15. Weber HP, Gray RW, Dominguez JH, Lemann J Jr. The lack of effect of chronic metabolic acidosis on 25-hydroxyvitamin D metabolism and serum parathyroid hormone in humans. J Clin Endocrinol Metab. 1976; 43:1047-55.10.1210/jcem-43-5-1047993311
- 16. Krapf R, Vetsch R, Vetsch W, Hulter HN. Chronic metabolic acidosis increases the serum concentration of 1, 25 dihydroxyvitamin D in humans by stimulating its production rate. Critical role of acidosis-induced renal hypophosphatemia. J Clin Invest. 1992; 90: 2456-63.10.1172/JCI1161374434021469097
- 17. Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest. 1994; 93:2127-33.10.1172/JCI117208
- 18. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome system. N Engl J Med. 1996; 335:1897-905.10.1056/NEJM199612193352507
- 19. Rajan VR, Mitch WE. Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact. Pediatr Nephrol. 2008; 23:527-35.10.1007/s00467-007-0594-z
- 20. Mak RH. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int. 1998; 54:603-7.10.1046/j.1523-1755.1998.00023.x
- 21. Schambelan M, Sebastian A, Katuna A, Arteaga E. Adrenocortical hormone secretory response to chronic NH4Cl-induced metabolic acidosis. Am J Physiol. 2001; 252:E454-60.10.1152/ajpendo.1987.252.4.E454
- 22. Salusky IB, Kuizon BG, Juppner H. Special aspects of renal osteodystrophy in children. Sem Nephrol. 2004; 24:69-77.10.1053/j.semnephrol.2003.08.009
- 23. Abitbol CL, Warady BA, Massie MD, Baluarte JH, Fleischman LE, Geary DF, et al. Linear growth and anthropometric and nutritional measurements in children with mild to moderate renal insufficiency: a report of the growth failure in children with renal diseases study. J Pediatr. 1990; 116:S46-54.10.1016/S0022-3476(05)82925-7
- 24. Challa A, Krieg RJ Jr, Thabet MA, Veldhuis JD, Chan JCM. Metabolic acidosis inhibits growth hormone secretion in rats: mechanism of growth retardation. Am J Physiol. 1993; 265:E547-53.10.1152/ajpendo.1993.265.4.E5478238328
- 25. Challa A, Chan W, Krieg RJ Jr, Thabet MA, Liu F, Hintz RL, et al. Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor. Kidney Int. 1993; 44:1224-7.10.1038/ki.1993.3728301923
- 26. Santos F, Chan JCM, Krieg RJ, Niimi K, Hanna JD, Wellons MD, et al. Growth hormone secretion from pituitary cells in chronic renal insufficiency. Kidney Int. 1992; 41:356-60.10.1038/ki.1992.491552708
- 27. Brungger M, Hulter HN, Krapf R. Effect of chronic metabolic acidosis on thyroid hormone homeostasis in humans. Am J Physiol. 1997; 272:E648-53.10.1152/ajprenal.1997.272.5.F6489176376
- 28. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH. Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol. 1997; 8:627-31.10.1681/ASN.V8462710495792
- 29. Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz RM, et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF Receptor 1. Am J Physiol. 2009; 297:F282-91.10.1152/ajprenal.90742.2008272425819515808
- 30. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. New Engl J Med. 2008; 359:584-92.10.1056/NEJMoa0706130289026418687639
- 31. Hsu C. FGF-23 and outcomes research - when physiology meets epidemiology. New Engl J Med. 2008; 359: 640-2.10.1056/NEJMe080466018687647
- 32. Chan JCM, Scheinman JI, Roth KS. Renal tubular acidosis. Pediatr Rev. 2001; 22:277-86.10.1542/pir.22-8-27711483854
- 33. Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomed. 2007; 1:33-44.